CHANDAN

Chandan Healthcare Share Price

₹205.10 -2.9 (-1.39%)

12 Jul, 2025 02:20

SIP TrendupStart SIP in CHANDAN

Start SIP

Performance

  • Low
  • ₹204
  • High
  • ₹210
  • 52 Week Low
  • ₹140
  • 52 Week High
  • ₹225
  • Open Price₹209
  • Previous Close₹208
  • Volume29,600

Investment Returns

  • Over 1 Month + 9.74%
  • Over 3 Month -3.89%
  • Over 6 Month + 28.99%
  • Over 1 Year + 28.99%
SIP Lightning

Smart Investing Starts Here Start SIP with Chandan Healthcare for Steady Growth!

Invest Now

Chandan Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 22.6
  • PEG Ratio
  • -
  • Market Cap Cr
  • 502
  • P/B Ratio
  • 8.5
  • Average True Range
  • 9.9
  • EPS
  • 9.07
  • Dividend Yield
  • 0
  • MACD Signal
  • 2.94
  • RSI
  • 55.18
  • MFI
  • 49.51

Chandan Healthcare Financials

Chandan Healthcare Technicals

EMA & SMA

Current Price
₹205.10
-2.9 (-1.39%)
pointer
  • stock-down_img
  • Bearish Moving Average 2
  • stock-up_img
  • Bullish Moving Average 9
  • 20 Day
  • ₹200.21
  • 50 Day
  • ₹194.22
  • 100 Day
  • -
  • 200 Day
  • -

Resistance and Support

206.37 Pivot Speed
  • R3 214.73
  • R2 212.37
  • R1 208.73
  • S1 202.73
  • S2 200.37
  • S3 196.73

What's your outlook on Chandan Healthcare?

You can only vote once!

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Chandan Diagnostics is a leading healthcare provider with 50+ centers and 500 collection points across Uttar Pradesh, Uttarakhand, and Rajasthan. Offering 3,500+ tests across multiple specialties, it ensures high-quality diagnostics with ISO and NABL-certified labs, cutting-edge automation, and seamless digital access.

Chandan Healthcare Ltd has an operating revenue of Rs. 663.16 Cr. on a trailing 12-month basis. An annual revenue growth of 30% is outstanding, Pre-tax margin of 14% is healthy, ROE of 18% is exceptional. The company has a reasonable debt to equity of 18%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 13% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around -3% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 60 which is a FAIR score but needs to improve its earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 21 indicates it belongs to a strong industry group of Medical-Outpnt/Hm Care and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Chandan Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-27 Audited Results

Chandan Healthcare F&O

Chandan Healthcare Shareholding Pattern

49.43%
3.86%
33%
13.71%

About Chandan Healthcare

  • NSE Symbol
  • CHANDAN
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Amar Singh
  • ISIN
  • INE0B2N01016

Similar Stocks to Chandan Healthcare

Chandan Healthcare FAQs

Chandan Healthcare share price is ₹205 As on 12 July, 2025 | 02:06

The Market Cap of Chandan Healthcare is ₹501.5 Cr As on 12 July, 2025 | 02:06

The P/E ratio of Chandan Healthcare is 22.6 As on 12 July, 2025 | 02:06

The PB ratio of Chandan Healthcare is 8.5 As on 12 July, 2025 | 02:06

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23